That will change when results of the phase 3 randomized SELECT trial (NCT03574597) are released, perhaps as soon as 2023 or early 2024
Compounded semaglutide with L-Carnitine is a customized version of semaglutide created by a licensed compounding pharmacy
Common (1-10 in 100 people): vomiting, constipation, stomach pain, injection-site redness, fatigue, mild low blood sugar when used with other diabetes drugs
But is it advisable
FAQ #2: Is retatrutide FDA approved
Contact your provider immediately if you experience vomiting, inability to keep food or liquids down for more than a few hours, signs of dehydration (dark urine, excessive thirst, dizziness), or abdominal pain